Actively Recruiting
OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
Led by Luzerner Kantonsspital · Updated on 2023-10-06
4000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with PCI as well as prospectively collect the clinical outcome data. Outcomes will be compared in different clinical subgroups. The impact of PCI in AMI in general as well as cardiovascular outcomes after AMI will be assessed.
CONDITIONS
Official Title
OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject >18 years of age
- Diagnosed with acute myocardial infarction (STEMI or NSTEMI) within the last 5 years
- Willing to provide informed consent or have a proxy willing to provide consent
You will not qualify if you...
- Unwilling or unable to provide informed consent
- No acute coronary syndrome or myocardial infarction (e.g., Takotsubo cardiomyopathy, acute heart failure not related to AMI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Luzerner Heart Centre
Lucerne, Switzerland, 6000
Actively Recruiting
Research Team
F
Florim Cuculi, M.D.
CONTACT
M
Matthias Bossard, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here